Skip to main content
Egyptian Journal of Medical Human Genetics

Table 5 Drug-likeness parameters including bioavailability (BA) and synthetic accessibility (SA) of the selected compounds

From: Computational evaluation of potent 2-(1H-imidazol-2-yl) pyridine derivatives as potential V600E-BRAF inhibitors

Lipinski’s rule

Veber’s rule

SN

Mol. wt.

HBA

HBD

Log P

NRB

TPSA (Å2)

BA

SA

14

520.29

7

3

2.95

8

99.77

0.55

3.04

21

452.29

4

3

2.16

7

99.77

0.55

2.85

26

531.19

4

3

2.74

7

99.77

0.55

2.96

30

452.29

4

3

2.16

7

99.77

0.55

2.83

Vem.

489.92

6

2

4.97

7

100.30

0.55

3.38

  1. Mol. wt. molecular weight, HBA hydrogen bond acceptor, HDB hydrogen bond donor, NRB number of rotatable bonds, TPSA topological polar surface area
Back to article page